At the Intersection of Research and Treatment: Interviews with MSK Physician-Researchers

Dr. Luis Diaz, Jr., left, and Dr. Michael Postow, right.

Dr. Luis Diaz, Jr., left. and Dr. Michael Postow, right. Photos by Rick DeWitt (l) and Chad Hunt (r).

Two MSK physician-researchers were profiled in the media last month.

Fast Company spoke with Dr. Luis Diaz, Jr., Head of the Division of Solid Tumor Oncology. Dr. Diaz co-led a clinical trial of an immunotherapy for rectal cancer that proved effective without the need for surgery in all 14 participating patients. He aims to expand this research to cancers that are usually treated by extensive, life-altering surgeries, like esophageal, pancreatic, and stomach malignancies.

Becker’s Hospital Review interviewed Dr. Michael Postow, Chief of MSK’s Melanoma Service. Dr. Postow is excited about the growing efficacy of immunotherapies and the progress vaccines are making in cancer care. His research is motivated in part by the awareness that current treatment modalities do not yet help every patient; we have miles to go to improve care for everyone.

Unraveling the Complexities of Metastasis

Dr. Adrienne Boire

Adrienne Boire, MD, PhD. Photo: Karsten Moran.

An April feature in The Scientist explores the current landscape of metastasis research.

Framing the story is the work of MSK’s Dr. Adrienne Boire. When she was a clinical and postdoctoral fellow at MSK, a young patient asked her why and how cancer metastasized to her spinal fluid.

The interaction changed the focus of Boire’s research. She now leads a lab at MSK where she and her collaborators are making inroads into understanding the biology of metastatic cells.

Learn more about the Boire Lab in this 2019 video.